Papers by Salim Yusuf
Page 7 · newest first
- P2837Day-case complex left atrial ablation is safe and cost-effective: experience from a UK tertiary centreEuropean Heart Journal · 2019
- Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke SubtypesJAMA Neurology · 2019
- Bleeding and New Cancer Diagnosis in Patients With AtherosclerosisCirculation · 2019
- Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus AspirinJournal of the American College of Cardiology · 2019
- Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular diseaseEuropean Heart Journal - Cardiovascular Imaging · 2019
- Association between complications and death within 30 days after noncardiac surgeryCanadian Medical Association Journal · 2019
- Associations of cardiometabolic outcomes with indices of obesity in children aged 5 years and youngerPLoS ONE · 2019
- Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes RiskDiabetes Care · 2019
- Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery DiseaseCirculation · 2019
- Digoxin–mortality: randomized vs. observational comparison in the DIG trialEuropean Heart Journal · 2019
- Systematic scoping review protocol of methodologies of chronic respiratory disease surveys in low/middle-income countriesnpj Primary Care Respiratory Medicine · 2019
- Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal DysfunctionJournal of the American College of Cardiology · 2019
- Health Effects of Household Solid Fuel Use: Findings from 11 Countries within the Prospective Urban and Rural Epidemiology StudyEnvironmental Health Perspectives · 2019
- Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) studyThe Lancet Global Health · 2019
- Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort studyThe Lancet Global Health · 2019
- Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countriesJournal of Hypertension · 2019
- Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular riskEuropean Heart Journal · 2019
- Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort studyBMJ · 2019
- Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and designAmerican Heart Journal · 2019
- Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trialCanadian Medical Association Journal · 2019
- Effects of blood pressure and lipid lowering on cognitionNeurology · 2019
- Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trialDiabetes Obesity and Metabolism · 2019
- Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trialEP Europace · 2019
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trialsThe Lancet · 2019
- Stroke Outcomes in the COMPASS TrialCirculation · 2019
- Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic GroupsCirculation · 2019
- The cost implication of primary prevention in the HOPE 3 trialEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2019
- Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trial2019
- Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 studyEuropean Journal of Preventive Cardiology · 2018
- Effects of blood pressure lowering on cardiovascular events, in the context of regression to the meanJournal of Hypertension · 2018
- Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trialsEuropean Heart Journal · 2018
- Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countriesEuropean Heart Journal · 2018
- Digoxin and clinical outcomes in the Global Rheumatic Heart Disease RegistryHeart · 2018
- Evolving evidence about diet and healthThe Lancet Public Health · 2018
- The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conductAmerican Heart Journal · 2018
- Evaluation of Biological Oxygen Demand (BOD) and Chemical Oxygen Demand (COD) Removal from Tannery Wastewater using Activated Carbon from Terminalia catappa NutshellsJournal of Energy and Environmental Sustainability · 2018
- Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialInternational Journal of Stroke · 2018
- Implementation of 100% smoke-free law in Uganda: a qualitative study exploring civil society’s perspectiveBMC Public Health · 2018
- Effects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 TrialJournal of the American Heart Association · 2018
- Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery DiseaseJournal of the American College of Cardiology · 2018
- Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) StudyAmerican Heart Journal · 2018
- Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK92018
- Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsEuropean Heart Journal · 2018
- Neurobiochemical Roles of Low Molecular Weight Antioxidants on Oxidative Stress Biomarkers and Severity of Ischemic Stroke in Wistar RatsJournal of Neurology and Neurological Disorders · 2018
- Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataPLoS Medicine · 2018
- Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac SurgeryAnnals of Internal Medicine · 2018
- Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrumEuropean Journal of Heart Failure · 2018
- Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational studyThe Lancet Global Health · 2018
- Impact of abdominal aortic aneurysm screening on quality of lifeBritish journal of surgery · 2018
- A novel two – factor high order fuzzy time series with applications to temperature and futures exchange forecastingNigerian Journal of Technology · 2018